You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR VANCOCIN HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for VANCOCIN HYDROCHLORIDE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00384527 ↗ Study of Nitazoxanide in the Treatment of Clostridium Difficile-associated Disease Terminated Romark Laboratories L.C. Phase 3 2006-12-01 The primary objective of the study is to demonstrate non-inferiority of nitazoxanide compared to vancomycin in resolving symptoms of Clostridium difficile-associated disease (CDAD).
NCT00428844 ↗ Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci Completed Cubist Pharmaceuticals LLC Phase 2 2007-06-26 This is a research study designed to look at the efficacy and safety of daptomycin given at a dose of 6 mg/kg or 8 mg/kg in subjects being treated for prosthetic hip or knee infections caused by Staphylococci. These types of bacteria are among the most common types of bacteria causing infections of prosthetic joints.
NCT00430937 ↗ Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections Terminated Novartis Pharmaceuticals Phase 3 2006-04-01 This study evaluated the efficacy and safety of daptomycin compared to vancomycin or teicoplanin for the treatment of complicated skin and soft tissue infections
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for VANCOCIN HYDROCHLORIDE

Condition Name

Condition Name for VANCOCIN HYDROCHLORIDE
Intervention Trials
Clostridium Difficile Infection 5
Clostridium Difficile 3
Primary Sclerosing Cholangitis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for VANCOCIN HYDROCHLORIDE
Intervention Trials
Clostridium Infections 10
Infections 7
Infection 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for VANCOCIN HYDROCHLORIDE

Trials by Country

Trials by Country for VANCOCIN HYDROCHLORIDE
Location Trials
United States 134
Canada 9
United Kingdom 6
France 4
Romania 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for VANCOCIN HYDROCHLORIDE
Location Trials
Texas 8
Florida 8
Georgia 7
California 7
Ohio 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for VANCOCIN HYDROCHLORIDE

Clinical Trial Phase

Clinical Trial Phase for VANCOCIN HYDROCHLORIDE
Clinical Trial Phase Trials
Phase 4 8
Phase 3 8
Phase 2/Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for VANCOCIN HYDROCHLORIDE
Clinical Trial Phase Trials
Completed 22
Terminated 6
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VANCOCIN HYDROCHLORIDE

Sponsor Name

Sponsor Name for VANCOCIN HYDROCHLORIDE
Sponsor Trials
Cubist Pharmaceuticals LLC 3
Mayo Clinic 3
Henry Ford Hospital 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for VANCOCIN HYDROCHLORIDE
Sponsor Trials
Other 38
Industry 17
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.